MarketPeel
Insider Trading Intelligence
JC

Jennifer Champoux

GLUE
CHIEF OPERATING OFFICER · MONTE ROSA THERAPEUTICS, INC. · CIK 0002025233
FILING MIX · LIFETIME50%/50%
BUYS
9
SELLS
9
TOTAL VALUE
$244.2K
COMPANIES
1
ACTIVE SINCE
Jun 2024
HOLDINGS NOW
31,298
AVG SELL PX
$18.50
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Jennifer Champoux, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+64.72%+1.08%+63.64%+63.64%
14d1+0.00%+69.72%-1.47%+71.20%+71.20%
30d1+0.00%+35.63%-0.22%+35.85%+35.85%
60d1+0.00%+23.61%-2.23%+25.84%+25.84%
90d1+0.00%+17.57%-4.19%+21.76%+21.76%
180d1+0.00%+68.13%+8.30%+59.83%+59.83%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GLUE · 31,298 shares · as of Jun 23, 2026
039,50079,000118,500158,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 9 buys / 9 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,17531,298Jun 23, 2026Jun 25, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,175$20.00$43.5K62,371Jun 23, 2026Jun 25, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,175$3.98$8.7K64,546Jun 23, 2026Jun 25, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,176$3.98$8.7K64,547Jun 17, 2026Jun 18, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,17633,473Jun 17, 2026Jun 18, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,176$19.00$41.3K62,371Jun 17, 2026Jun 18, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,175$3.98$8.7K64,546May 27, 2026May 28, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,175$20.00$43.5K62,371May 27, 2026May 28, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,17535,649May 27, 2026May 28, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,176$19.00$41.3K62,371May 22, 2026May 26, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,17637,824May 22, 2026May 26, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,176$3.98$8.7K64,547May 22, 2026May 26, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,629$15.17$39.9K62,371Jan 5, 2026Jan 5, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,00065,000Jan 2, 2026Jan 5, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
158,000158,000Jan 2, 2026Jan 5, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jan 2, 2025Jan 6, 2025View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
135,000135,000Jan 2, 2025Jan 6, 2025View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 3, 2024Jun 5, 2024View →
Other insiders · GLUE
Loading peer insiders…
About this filer
CIK 0002025233
ROLE
Chief Operating Officer
PRIMARY
GLUE
COMPANIES
1
ACTIVE SINCE
Jun 2024
MARKETPEEL · /INSIDER/0002025233DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback